Alphamab Oncology
HKEX:9966
Wall Street
Price Targets
Price Targets Summary
Alphamab Oncology
According to Wall Street analysts, the average 1-year price target for
Alphamab Oncology
is 5.1 HKD
with a low forecast of 5.05 HKD and a high forecast of 5.25 HKD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Alphamab Oncology's stock price target?
Price Target
5.1
HKD
According to Wall Street analysts, the average 1-year price target for
Alphamab Oncology
is 5.1 HKD
with a low forecast of 5.05 HKD and a high forecast of 5.25 HKD.
What is Alphamab Oncology's Revenue forecast?
Projected CAGR
39%
The
compound annual growth rate
of Alphamab Oncology's revenue for the next 3 years is
39%.
What is Alphamab Oncology's Operating Income forecast?
Projected CAGR
97%
The
compound annual growth rate
of Alphamab Oncology's operating income for the next 3 years is
97%.
What is Alphamab Oncology's Net Income forecast?
Projected CAGR
65%
The
compound annual growth rate
of Alphamab Oncology's net income for the next 3 years is
65%.
You don't have any saved screeners yet
